VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Digital sorting of complex tissues for cell type-specific gene expression profiles.
MicroRNAs, ultraconserved genes and colorectal cancers.
Overcoming the reimbursement barriers for clinical sequencing.
Vaccine innovations for emerging infectious diseases-a symposium report.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma. N Engl J Med. 2018 01 25; 378(4):331-344.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Bleomycin
Dacarbazine
Disease-Free Survival
Doxorubicin
Female
Follow-Up Studies
Hodgkin Disease
Humans
Immunoconjugates
Immunologic Factors
Male
Middle Aged
Neoplasm Staging
Neutropenia
Survival Rate
Vinblastine
Young Adult
authors with profiles
YASUHIRO OKI